Dyslipidemia Treatment by Traditional Chinese Medicine: A Systematic Review
Article Sidebar
Main Article Content
Abstract
Dyslipidemia is a significant non-communicable disease among adult populations globally. This systematic review focused on understanding current case management using traditional Chinese medicine (TCM) internal and external treatments, integrated TCM, and Western medicine, including other genomic research related to dyslipidemia. This could be used to understand the effectiveness of the care and management of patients with dyslipidemia based on different medical principles. Finally, the information can be used to support clinical decisions to choose the best approach for the care and management of patients.
Article Details
JHSAM publishes all articles in full open access, meaning unlimited use and reuse of articles with appropriate credit to the authors.
All our articles are published under a Creative Commons "CC-BY-NC-ND 4.0". License which permits use, distribution and reproduction in any medium,
provided that the original work is properly cited and is used for noncommercial purposes.
References
Liu JJ, Jia LQ, Lyu MJ, Yang GL. Research progress in combination of traditional Chinese and western medicine in hyperlipidemia. Chinese Archives of Traditional Chinese Medicine. 2017;35(04):815-818.
Tang MJ. Clinical study of dyslipidemia treated by combined therapy of traditional Chinese medicine and western medicine. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine. 2019;7(02):148-149.
Du YK, Ling W, Wang DQ. Research progress of acupuncture and moxibustion treatment of dyslipidemia based on Sanjiao gasification theory. Hunan Journal of Traditional Chinese Medicine. 2021;37(02):163-166.
Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids in Health and Disease. 2019;18(1):90.
Liang X, Ye M, Tao M, Zheng D, Cai R, Zhu Y, et al. The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study. BMC Nephrology. 2020;21(1):252.
Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the risk of developing hypertension in a working-age male population. Journal of the American Heart Association. 2016;5(3): e003053-e.
Hakobyan S, Hakobyan S, Zohrabyan N. The connection of diabetic dyslipidemia and erectile dysfunction. Diabetes & Metabolism. 2016;42(4):297.
Jiang S, Jiang J, Xu H, Wang S, Liu Z, Li M, et al. Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: A meta-analysis. Taiwanese Journal of Obstetrics and Gynecology. 2017;56(1):9-15.
Li J, Liu H, Liao WL. Clinical observation on treating hyperlipidemia plus carotid atherosclerosis plaque with the Erchen decoction plus Siwu decoction. Clinical Journal of Chinese Medicine. 2019;11(11):37-39.
Zhang JL, Liao H, Sheng RD, Yang DQ, Liu BH, Cheng HS, et al. Clinical effect of Jiangya Tiaozhi decoction in treatment of hypertension and hyperlipidemia with phlegm-turbidity stagnation: An analysis of 30 cases. Hunan Journal of Traditional Chinese Medicine. 2019;35(07):5-7.
Xing QS. Clinical observation of Banxia Baizhu Tianma decoction combined with Xuefuzhuyu decoction in treatment of hypertension and dyslipidemia. Journal of Practical Traditional Chinese Medicine. 2017;33(02):125-126.
Liang YK. Clinical observation of Tongyuhuazhuo decoction in treatment of dyslipidemia: An analysis of 64 cases. Journal of New Chinese Medicine. 2016;48(06):18-19.
Tang MY, Zheng AH. Clinical observation of Sanshen Tiaozhi decoction in treatment of dyslipidemia with spleen deficiency and phlegm stasis: An analysis of 30 cases. Hunan Journal of Traditional Chinese Medicine. 2016;32(02):43-45.
Zhang J. Clinical observation of Huatan Jiangzhi decoction in treatment of dyslipidemia. Journal of Sichuan of Traditional Chinese Medicine. 2016;34(08):82-83.
Zhong ZM. Clinical observation and nursing experience of acupoint catgut embedding combined with body acupuncture in treatment of dyslipidemia with phlegm dampness obstruction. Journal of External Therapy of TCM. 2020;29(02):76-77.
Peng YW. Clinical effect of ear acupuncture combined with warming needle moxibustion on obese female with dyslipidemia of spleen kidney yang deficiency. Inner Mongolia Journal of Traditional Chinese Medicine. 2019;38(06):88-89.
Xiao XT, Wen Z, Ye ZL, Lin GH, Yu ZF, Chen HD. Observation on therapeutic effect of acupoint catgut embedding combined with thunder fire moxibustion on hyperlipidemia of spleen kidney yang deficiency. Shanghai Journal of Acupuncture and Moxibustion. 2018;37(03):289-292.
Chen ZJ, Wu ZC, Wang JJ, Han B, Pang L, Wang WY, et al. Clinical observation of Moxibustion based on syndrome differentiation in treatment of dyslipidemia: an analysis of 49 cases. Journal of Traditional Chinese Medicine. 2015;56(22):1935-1938.
Wang KY, Liu ZC, Xu B. Clinical observation on electro-acupuncture combined with ear-acupuncture in treating patients with obesity of stomach-intestine excessive heat type complicated with hyperlipidemia. China Journal of Traditional Chinese Medicine and Pharmacy. 2015;30(12):4513-4516.
Liu M, Li ZH, Ma H. Effect of Jianpi Huashi therapy combined with western medicine in the treatment of hyperlipidemia in spleen deficiency with phlegm-dampness pattern. World Journal of Integrated Traditional and Western Medicine. 2020;15(04):589-592-596.
Zuo L, Wang JY, Cui DW. Clinical observation on 58 cases of hypertension combined with hyperlipidemia of phlegm-dampness stagnation type treated by Banxia Baizhu Tianma decoction combined with Western Medicine. Chinese Journal of Ethnomedicine and Ethnopharmacy. 2020;29(09):110-114.
Chen K, Xue Y, Zhu L. Clinical observation of Qutan Huazhuo decoction combined with Atorvastatin in treatment of dyslipidemia. Chinese Journal of Traditional Medical Science And Technology. 2020;27(03):410-411.
Wang HY, Liu LL, Lu WT, Liu JQ, Hao SS. Analysis of the curative effect of Huatan Huoxue therapy combined with western medicine in treating hyperlipidemia and vascular endothelial dysfunction. Clinical Journal of Chinese Medicine. 2020;12(30):69-72.
Zuo YS, Liu L. Therapeutic effects of Huoxue Huayu Jiangzhi decoction combined with simvastatin capsule on hyperlipidemia. Hebei Medical Journal. 2019;41(08):1214-1217.
Lin XZ. Clinical observation of Dantian Shenzhu decoction in treatment of dyslipidemia with spleen deficiency and phlegm stasis. Guangming Journal of Chinese Medicine. 2018;33(04):521-523.
Zheng XQ. Clinical observation of Hedan Zhaze decoction combined with Atorvastatin Calcium tablets in treatment of dyslipidemia. Journal of New Chinese Medicine. 2015;47(09):24-25.
Li ZW, Wang Y, Du HX, He Y, Wan HT, Yang JH. Effects and mechanisms of Danhong injection on cerebral ischemia-reperfusion injury in rats with hyperlipemia. Chinese Pharmaceutical Journal. 2020;55(15):1259-1265.
Wang Q, Liu Y, Fu JQ, Xue Q, Yan P. Effect of oral liquid of Rosa Roxburghii Tratt and Crataegus Pinnatifida on the lipid metabolism and LPL gene in patients with hyperlipidemic pancreatitis. Journal of Southwest Medical University. 2020;43(01):28-31.
Xiao FQ, He Q, Shao S, Qiu MY, Wang TN, Zhang RR, et al. Effects of Hedan Sanqi Jiangzhi tablet and Nrf2、γ-GCS gene mRNA expression in rats with hyperlipidemia. Chinese Journal of Hospital Pharmacy. 2019;39(24):2473-2478.
Zhang YD, Jiang XY, Cao LJ, Wang J, Jiang CH, Zhao MG, et al. Gypenoside granules improved lipid metabolism in C57BL/6J mice with hyperlipidemia. Journal of China Pharmaceutical University. 2019;50(06):713-720.
Wang YF, Han X, Zhang YX, Duan SM, Hao L, Wang X, et al. Effects of modified Rhizoma Alismatis decoction on expression of AQP3 in rats with hyperlipidemia. Natural Product Research and Development. 2017;29(10):1671-1676, 1711.
Wu Y, Zhu F, Liu JP, Li YM. Effects of Sini powder on blood lipid metabolism in mice with hyperlipidemia. Global Traditional Chinese Medicine. 2016;9(12):1450-1454.
Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European Heart Journal. 2015;36(17):1012-1022.
Casula M, Mozzanica F, Scotti L, Tragni E, Pirillo A, Corrao G, et al. Statin use and risk of new-onset diabetes: a meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases. 2017;27(5):396-406
Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, et al. Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2016;134(21):e468-e495
Xie W, Zhao Y, Du L. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia. Journal of Ethnopharmacology. 2012;140(2):345-367
An DQ, Wu ZG, Liang C, Lin Q, Liu ZY, Liu HX, et al. Expert consensus on the diagnosis and treatment of dyslipidemia by combination of traditional Chinese and western medicine. Chinese General Practice. 2017;20(03):262-269
Chan K, Zhang H, Lin Z-X. An overview on adverse drug reactions to traditional Chinese medicines. British Journal of Clinical Pharmacology. 2015;80(4):834-843
Wu J, Hu Y, Zhu Y, Yin P, Litscher G, Xu S. Systematic Review of Adverse Effects: A Further Step towards Modernization of Acupuncture in China. Evidence-Based Complementary and Alternative Medicine. 2015;2015:432467.